Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7426
PUT
Transmedics
TMDX
$3.07B
| $679K | ﹤0.01% |
+34,100
| New | +$505K |
|
7427
CALL
CVR Energy
CVI
$3.54B
| $678K | ﹤0.01% |
45,500
-14,200
| -24% | -$192K |
|
7428
Brookfield Renewable
BEPC
$6.59B
| $676K | ﹤0.01% |
11,598
-175,559
| -94% | -$8.44M |
|
7429
PUT
Cimpress
CMPR
$2.3B
| $676K | ﹤0.01% |
7,700
-600
| -7% | -$51.5K |
|
|
ECOM
7430
PUT
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $676K | ﹤0.01% |
42,300
-7,400
| -15% | -$117K |
|
7431
CALL
America Movil
AMX
$70.3B
| $675K | ﹤0.01% |
46,400
-11,600
| -20% | -$157K |
|
|
APLS
7432
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $675K | ﹤0.01% |
11,800
-100
| -0.8% | -$4.23K |
|
7433
Neurogene
NGNE
$723M
| $675K | ﹤0.01% |
2,393
-15,845
| -87% | -$3.87M |
|
|
IVC
7434
DELISTED
Invacare Corporation
IVC
| $675K | ﹤0.01% |
75,489
+58,255
| +338% | +$484K |
|
7435
Mercantile Bank Corp
MBWM
$1.06B
| $673K | ﹤0.01% |
24,744
+3,219
| +15% | +$76.9K |
|
7436
RPC Inc
RES
$1.41B
| $673K | ﹤0.01% |
213,780
-50,291
| -19% | -$151K |
|
7437
Procure Space ETF
UFO
$634M
| $673K | ﹤0.01% |
26,430
+3,415
| +15% | +$80.4K |
|
7438
The Greenbrier Companies
GBX
$1.41B
| $672K | ﹤0.01% |
18,485
-89,115
| -83% | -$2.94M |
|
7439
Cambria Global Momentum ETF
GMOM
$72.6M
| $672K | ﹤0.01% |
25,920
-907
| -3% | -$22.5K |
|
7440
PUT
Textron
TXT
$15.3B
| $672K | ﹤0.01% |
13,900
-22,800
| -62% | -$959K |
|
7441
McEwen Inc
MUX
$1.15B
| $671K | ﹤0.01% |
68,117
+24,197
| +55% | +$247K |
|
7442
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
| $671K | ﹤0.01% |
9,435
-12,634
| -57% | -$808K |
|
7443
CALL
Teekay Tankers
TNK
$2.95B
| $671K | ﹤0.01% |
60,900
+31,200
| +105% | +$345K |
|
7444
Castle Biosciences
CSTL
$905M
| $670K | ﹤0.01% |
9,989
-49,807
| -83% | -$2.7M |
|
7445
CALL
MacroGenics
MGNX
$269M
| $670K | ﹤0.01% |
29,300
+2,100
| +8% | +$48.3K |
|
|
SPTN
7446
PUT
DELISTED
SpartanNash
SPTN
| $670K | ﹤0.01% |
38,500
+25,900
| +206% | +$483K |
|
7447
Calumet Specialty Products
CLMT
$4.19B
| $669K | ﹤0.01% |
213,665
-47,249
| -18% | -$165K |
|
7448
Glacier Bancorp
GBCI
$6.5B
| $669K | ﹤0.01% |
14,537
-124,075
| -90% | -$5.01M |
|
7449
CALL
Pilgrim's Pride
PPC
$6.64B
| $669K | ﹤0.01% |
34,100
-10,200
| -23% | -$185K |
|
|
SCPL
7450
PUT
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $669K | ﹤0.01% |
48,300
+15,800
| +49% | +$230K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.